GlassScriptPhysician profile
Arshad Ahad
NPI 1487647293
$816.01
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.86 · 2022: $780 · 2023: $18.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $97.88 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $94.20 | 2022 | |
| Genentech USA, INC. | $67.22 | 2022 | |
| Emmaus Medical, INC. | $52.99 | 2022 | |
| Genzyme Corporation | $44.77 | 2022 | |
| Amgen INC. | $40.21 | 2022 | |
| Gilead Sciences, INC. | $40.19 | 2022 | |
| Boston Scientific Corporation | $35.75 | 2020-2023 | Bodyguardian |
| Karyopharm Therapeutics INC. | $32.45 | 2022 | |
| Incyte Corporation | $28.57 | 2022 | |
| Exelixis INC. | $28.00 | 2022 | |
| Seagen INC. | $25.17 | 2022 | |
| Jazz Pharmaceuticals INC. | $24.54 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $23.20 | 2022 | |
| Puma Biotechnology, INC. | $21.54 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $21.53 | 2022 | |
| Morphosys, US INC. | $20.84 | 2022 | |
| Eusa Pharma (US) LLC | $20.76 | 2022 | |
| Novartis Pharmaceuticals Corporation | $18.71 | 2022 | |
| Astellas Pharma US INC | $17.97 | 2022 | |
| Coherus Oncology, INC. | $16.38 | 2022 | |
| Rigel Pharmaceuticals, INC. | $16.02 | 2022 | |
| Organon LLC | $14.20 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $12.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arshad Ahad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.